Hypercalcemia Malignancy Factor (1-40) is a regulatory peptide fragment used to investigate parathyroid hormone–related structure and binding determinants. Its sequence supports mapping of helical regions and receptor-interaction motifs. Researchers apply it to analyze conformational plasticity across hormone fragments. The peptide aids biochemical exploration of peptide–protein interfaces.
CAT No: P03043
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More